Advertisement

Topics

Novartis Spreads Good News About Two Drugs at European Congress of Rheumatology

20:00 EDT 13 Jun 2018 | BioSpace

Novartis has walked into the European Congress of Rheumatology to make a case for two of its drugs, Cosentyx and canakinumab.

Original Article: Novartis Spreads Good News About Two Drugs at European Congress of Rheumatology

NEXT ARTICLE

More From BioPortfolio on "Novartis Spreads Good News About Two Drugs at European Congress of Rheumatology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...